<DOC>
	<DOCNO>NCT01033318</DOCNO>
	<brief_summary>The goal study identify least one safe well tolerate dose MK1809 similar pharmacokinetic quality 100 mg losartan .</brief_summary>
	<brief_title>A Study Pharmacokinetics Pharmacodynamics MK1809 ( 1809-001 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Part 1 : Nonsmoker least 6 month Body Mass Index ( BMI ) less equal 29 kg/m2 In overall good health Part 2 : Body Mass Index ( BMI ) great 18kg/m2 less equal 35kg/m2 In overall good health ( patient hypertension and/or hyperlipidemia accept ) Part 1 : History cardiovascular disease clinically significant family history cardiac arrhythmia conduction abnormality age less 60 year History major endocrine , vascular , hematologic , gastrointestinal , hepatic , renal genitourinary disease/disorder History cancer Clinically significant history neurological disorder ( include epilepsy , stroke , transient ischemic attack , classic migraine ) Active history psychiatric disorder ( include depression , bipolar disorder , schizophrenia , anxiety ) History asthma , severe wheezing , COPD , pulmonary disease Individual family history bleed hemorrhagic diathesis , bleed difficulty Major surgery , donate blood participate another investigational drug ( ) trial within 30 day Illicit drug use ( include recreational ) ; history drug alcohol abuse ( within 2 year ) Nitrate therapy within 4 week History significant drug allergy history food allergy Part 2 History clinically significant cardiac cardiovascular disease ( hypertension ) History major endocrine , vascular , hematologic , gastrointestinal , hepatic , renal genitourinary disease/disorder History cancer History neurological disorder ( include epilepsy , stroke , transient ischemic attack , classic migraine ) Active history psychiatric disorder ( include depression , bipolar disorder , schizophrenia , anxiety ) History asthma , severe wheezing , COPD , pulmonary disease Individual family history bleed hemorrhagic diathesis , bleed difficulty Illicit drug use ( include recreational ) ; history drug alcohol abuse ( within 2 year ) Surgery , significant blood loss , donate blood , participate another investigational drug ( ) trial within 30 day Nitrate therapy within 4 week History significant drug allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Hypertension</keyword>
</DOC>